Publications by authors named "Benoit Calderon"

Claim this Profile
N
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.
Jean Bourhis, Anne Aupérin, Christian Borel, Gautier Lefebvre, Severine Racadot, Benoit Calderon

Lancet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated radiotherapy for head and neck squamous cell carcinoma.
Dylan Bocha, Jennifer Le Guevelou, Cécile Ortholan, Benoît Calderon, Yoann Pointreau

Cancer Radiother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis.
Benoît Calderon, Léa Vazquez, Mohammed Belkacemi, Nicolas Pourel

Eur J Med Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Yungan Tao, Xu-Shan Sun, Yoann Pointreau, Christophe Le Tourneau, Christian Sire, Benôit Calderon

Eur J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Treatment-Induced Liver Toxicity.
Benoît Calderon, Alma Stancu, François-Roger Vanel, Léa Vazquez

Case Rep Gastroenterol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The management of bone metastasis].
Rémi Bonetto, Agnès Tallet, Anthony Mélot, Benoît Calderon, Fabrice Barlesi

Bull Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma.
Gwenaelle Gravis, Marjorie Faure, Stanislas Rybikowski, Slimane Dermeche, Marguerite Tyran, Benoit Calderon

Mol Clin Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for ovarian epithelial cancer in the elderly: a case-control study.
Renaud Sabatier, Benoît Calderon, Eric Lambaudie, Elisabeth Chereau, Magali Provansal

Int J Gynecol Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis